Dr. Goy on the Upcoming Conference at the JTCC

Dr. Andre Goy from John Theurer Cancer Center on the Upcoming Conference at John Theurer Cancer Center

Andre Goy, MD, MS, chairman, director, and chief of the Lymphoma Division at the John Theurer Cancer Center, recognizes that this is a very exciting time for the field of oncology. There are multiple novel therapies, predictors, and biomarkers currently being investigated. It is a daunting task for the busy oncology specialist to keep up on all this new information.

The upcoming New Frontiers in the Management of Solid and Liquid Tumors at John Theurer Cancer Center at Hackensack University Medical Center, November 3-4, 2011, will broadly explain the recent advances in these multiple fields. This information will help the clinician manage patients by facilitating the application of this knowledge into practice.

Learn more about the New Frontiers In The Management of Solid and Liquid Tumors.

Related Videos
Karl Semaan, MD, MSc
Bradley McGregor, MD, discusses findings from a phase 1b study of abemaciclib  in clear cell renal cell carcinoma.
Marc-Oliver Grimm, MD
Chun Chao, PhD, MS
Mikkael A. Sekeres, MD
Noa Biran, MD
Ranee Mehra, MD, professor, medicine, medical oncology; director, Head and Neck Medical Oncology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical System
Sumanta Kumar Pal, MD, FASCO, chair, Kidney and Bladder Cancer Disease Team; co-director, Kidney Cancer Program; professor, vice chair, Academic Affairs, Department of Medical Oncology & Therapeutics Research, City of Hope
Alfred L. Garfall, MD, MS
David Braun, MD, PhD